MedTrace Logo

Real-World Clinical Study for Malignant Tumor-Induced Cachexia

NCT07008248 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-08-08

No results posted yet for this study

Summary

This study is a non-interventional, multicenter observational study, aiming to assess the clinical characteristics and treatment outcomes of malignant tumor cachexia. The study is mainly divided into two cohorts:

Retrospective Cohort: This cohort focuses on patients who have already been diagnosed with cachexia before the initiation of this study. It involves the retrospective collection and analysis of clinical data.

Prospective Cohort: This cohort includes patients who are diagnosed with cachexia after the start of this study. Data will be prospectively collected and analyzed during their subsequent diagnosis and treatment process.

Conditions

  • Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia
  • Multicenter Observational Study

Sponsors & Collaborators

  • Xuzhou Central Hospital

    collaborator OTHER

  • Changchun GeneScience Pharmaceutical Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-15
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07008248 on ClinicalTrials.gov